Medications

FDA panel backs much-debated ALS drug in rare, 2nd review

A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig's disease, a remarkable turnaround for the much-debated medication that was previously rejected by the ...

Medical research

Cravings for fatty foods traced to gut-brain connection

A dieter wrestling with cravings for fatty foods might be tempted to blame their tongue: the delicious taste of butter or ice cream is hard to resist. But new research investigating the source of our appetites has uncovered ...

Neuroscience

Brain's support cells may hold key to new Huntington's treatments

Huntington's disease—a hereditary and fatal genetic disorder—has long been considered a neuronal disease due to the permanent loss of medium spiny motor neurons, the death of which over time is responsible for the clinical ...

Medical research

Can the protein that defeats metabolic diseases conquer dementia?

Alzheimer's disease is a representative neurodegenerative disease showing up at an increasing rate in an aging society. Sufferers of this disease are not only portrayed in media, but can often be seen around us. Patients ...

Neuroscience

Timing of neuron development determines what they can become

When it comes to royalty, things are clear: The monarch's first child inherits the crown. Siblings born later must make do with a less glamorous profession. This is quite similar for some nerve cells in the brain. In their ...

page 29 from 40